.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Argus Health
Chubb
Harvard Business School
UBS
US Army
Citi
Chinese Patent Office
Cerilliant
Johnson and Johnson

Generated: September 24, 2017

DrugPatentWatch Database Preview

SODIUM IODIDE I 131 Drug Profile

« Back to Dashboard

What is the patent landscape for Sodium Iodide I 131, and when can generic versions of Sodium Iodide I 131 launch?

Sodium Iodide I 131 is a drug marketed by Jubilant Draximage, Mallinkrodt Nuclear, and CIS. and is included in five NDAs.

The generic ingredient in SODIUM IODIDE I 131 is sodium iodide i-131. There are one thousand three hundred and ninety-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-131 profile page.

Summary for Tradename: SODIUM IODIDE I 131

Patents:0
Applicants:3
NDAs:5
Suppliers / Packagers: see list2
Clinical Trials: see list2,567
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SODIUM IODIDE I 131 at DailyMed

Pharmacology for Tradename: SODIUM IODIDE I 131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Draximage
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL021305-006May 19, 2005RXYesNo► Subscribe► Subscribe► Subscribe
Cis
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL017316-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Cis
SODIUM IODIDE I 131
sodium iodide i-131
SOLUTION;ORAL017315-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinkrodt Nuclear
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL016517-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Jubilant Draximage
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL021305-004Nov 18, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinkrodt Nuclear
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL016515-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Cis
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL017316-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinkrodt Nuclear
SODIUM IODIDE I 131
sodium iodide i-131
SOLUTION;ORAL016515-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Mallinkrodt Nuclear
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL016517-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
QuintilesIMS
Deloitte
Queensland Health
Johnson and Johnson
US Army
Accenture
Express Scripts
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot